Amgen
AMGN
1,865 hedge funds and large institutions have $85.5B invested in Amgen in 2019 Q2 according to their latest regulatory filings, with 107 funds opening new positions, 734 increasing their positions, 778 reducing their positions, and 109 closing their positions.
0.71% less ownership
Funds ownership: 77.11% → 76.4% (-0.71%)
2% less first-time investments, than exits
New positions opened: 107 | Existing positions closed: 109
6% less repeat investments, than reductions
Existing positions increased: 734 | Existing positions reduced: 778
1% less funds holding
Funds holding: 1,887 → 1,865 (-22)
6% less capital invested
Capital invested by funds: $90.9B → $85.5B (-$5.38B)
24% less funds holding in top 10
Funds holding in top 10: 71 → 54 (-17)
39% less call options, than puts
Call options by funds: $974M | Put options by funds: $1.59B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$823M |
| 2 |
BlackRock
New York
|
+$284M |
| 3 |
RL
Ruffer LLP
London,
United Kingdom
|
+$187M |
| 4 |
Barclays
London,
United Kingdom
|
+$116M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$104M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$687M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$686M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$201M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$191M |
| 5 |
State Street
Boston,
Massachusetts
|
-$137M |
AMGN Hedge Fund Activity: Q2 2019 in Review
1,865 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2019, worth a combined $85.5B — down 5.9% from $90.9B a quarter earlier.
Sellers outnumbered buyers: 109 funds closed out of AMGN and 107 opened new positions — a net loss of 2 holders — while 778 trimmed existing stakes and 734 added.
The largest buyer was Nuveen, adding an estimated $823M. The largest seller was Capital Research Global Investors, cutting an estimated $687M.
- 1,865 institutional investors held Amgen (AMGN) as of Q2 2019, down from 1,887 in Q1 2019.
- Funds reported $85.5B of Amgen stock for Q2 2019, down 5.9% quarter-over-quarter.
- 107 funds opened new Amgen positions in Q2 2019 and 109 closed out, a net change of -2 holders.
- The largest Amgen buyer in Q2 2019 was Nuveen, an estimated $823M added.
- The largest Amgen seller in Q2 2019 was Capital Research Global Investors, an estimated $687M sold.
Based on aggregated 13F filings for Q2 2019.